2021 Pediatric Grand Rounds | Leveraging Transcriptional Control to Find New Targeted Drugs for Pediatric Cancers

Duarte, CA US
February 4, 2021

New research techniques have been applied to studying pediatric cancers, allowing a deeper understanding of their biology and the associated therapeutic implications. As science progresses, it is imperative to stay updated in order to close the gap between current and ideal practice.

Pediatric cancers are often genomically quiet, so relying on sequencing to find "druggable" targets has not yet led to breakthroughs in many pediatric cancers. Understanding the impact of chromatin modifications on pediatric cancer gene expression is an emerging field. This activity will update the audience on how knowledge of the transcriptional landscape may have translational benefit for pediatric cancers, including leukemia.

Target Audience

Pediatric hematology/oncology physicians, nurses, nurse practitioners, clinical research, and social workers. 

Learning Objectives

  • Define a super-enhancer and the expected effect on the transcription of the gene it controls.
  • Describe the relevance of retinoid signaling in non-APL pediatric AML.
  • State the response rates of EZH2 inhibitors in children and young adults with rhabdoid tumors and what future trials will be studying.
     

Additional Information

AttachmentSize
PDF icon AB 1195 Bibliography158.56 KB
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Leveraging Transcriptional Control to Find New Targeted Drugs for Pediatric Cancers for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
02/04/2021
Activity expires: 
02/05/2021
Event starts: 
02/04/2021 - 12:00pm PST
Event ends: 
02/04/2021 - 1:00pm PST
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Joanna Yi, MD   Assistant Professor, Pediatric Hematology/Oncology; Texas Children's Hospital & Baylor College of Medicine. 

Dr. Yi has indicated she has nothing to disclose. 

Dr. Yi will be discussing the off-label or investigational use of Tazemetostat and Tamibarotene.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

 AMA PRA Category 1™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Leveraging Transcriptional Control to Find New Targeted Drugs for Pediatric Cancers for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.